Martin Meglasson

2007 - Ligand Pharmaceuticals

In 2007, Martin Meglasson earned a total compensation of $556.1K as Vice President, Discovery Research at Ligand Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$142,861
Option Awards$92,368
Salary$300,760
Stock Awards$12,757
Other$7,322
Total$556,067

Meglasson received $300.8K in salary, accounting for 54% of the total pay in 2007.

Meglasson also received $142.9K in non-equity incentive plan, $92.4K in option awards, $12.8K in stock awards and $7.3K in other compensation.

Rankings

In 2007, Martin Meglasson's compensation ranked 5,726th out of 8,700 executives tracked by ExecPay. In other words, Meglasson earned more than 34.2% of executives.

ClassificationRankingPercentile
All
5,726
out of 8,700
34th
Division
Manufacturing
2,150
out of 3,314
35th
Major group
Chemicals And Allied Products
465
out of 746
38th
Industry group
Drugs
315
out of 546
42nd
Industry
Pharmaceutical Preparations
230
out of 364
37th
Source: SEC filing on April 29, 2009.

Meglasson's colleagues

We found four more compensation records of executives who worked with Martin Meglasson at Ligand Pharmaceuticals in 2007.

2007

John Higgins

Ligand Pharmaceuticals

Chief Executive Officer

2007

Zofia Dziewanowska

Ligand Pharmaceuticals

Vice President, Clinical Research and Regulatory

2007

Charles Berkman

Ligand Pharmaceuticals

General Counsel

2007

John Sharp

Ligand Pharmaceuticals

Chief Financial Officer

You may also like